Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumor × trifluridine tipiracil drug combination × Clear all

Sponsor

Conditions

Colorectal Neoplasms 11 Neoplasm Metastasis 5 Stomach Neoplasms 2 Rectal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Gallbladder Neoplasms 2 Pancreatic Neoplasms 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Gastric Adenocarcinoma 1 Digestive System Diseases 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma 1 Bile Duct Neoplasms 1 Advanced or Metastatic Solid Tumors 1 Advanced Solid Tumors 1 Adenocarcinoma 1

Interventions

pertuzumab 2 durvalumab 2 Paclitaxel 2 Nivolumab 2 Docetaxel 2 Capecitabine 2 ulocuplumab 1 tremelimumab 1 tazarotene 1 talazoparib 1 romiplostim 1 pexidartinib 1 pembrolizumab 1 pamiparib 1 magrolimab 1 entrectinib 1 cobimetinib 1 atezolizumab 1 Sunitinib 1 Rifampin 1 Radiosurgery 1 Midazolam 1 LY3022855 1 LY2510924 1 Itraconazole 1 Irinotecan 1 Ipilimumab 1 Dextromethorphan 1 Carboplatin 1 CH5183284 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡